Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Dollar Tree logoDollar Tree DLTR

Dollar Tree said net sales for the 13-week period ended August 3, 2024 rose 0.7% to $7,372.7 million, and net income was $132.4 million, or $0.62 per diluted share, compared with $200.4 million, or $0.91, a year earlier.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Dollar Tree said net sales for the 13-week period ended August 3, 2024 rose 0.7% to $7,372.7 million, and net income was $132.4 million, or $0.62 per diluted share, compared with $200.4 million, or $0.91, a year earlier.

  2. The company said gross profit margin rose 80 basis points to 30.0% over the 13 weeks, selling, general and administrative expenses as a percentage of total revenue rose 200 basis points to 27.3%, and operating income margin was 2.8%. It cited unfavorable development of general liability claims as a factor in the higher SG&A expense rate.

  3. The company said it acquired designation rights for up to 170 leases of 99 Cents Only Stores in fiscal 2024 Q2, secured leases for 164 of these stores, and, as of August 3, 2024, had expanded its multi-price assortment to approximately 1,600 stores.

  4. The company said operating cash flow increased $78.8 million over the 26 weeks, and it repurchased 3,283,837 shares of common stock for $403.6 million. As of August 3, 2024, the principal amount of commercial paper outstanding was $250.0 million, and long-term debt was $3.45 billion.

Key figures

Quarter ended August 3, 2024

Revenue
$7.4B
Operating income
$203M
Net income
$132M
EPS
$0.62
Gross profit
$2.2B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q2 (13 weeks) net sales and net income

Dollar Tree said net sales for the 13-week period ended August 3, 2024 rose 0.7% to $7,372.7 million, and net income was $132.4 million, or $0.62 per diluted share, compared with $200.4 million, or $0.91, a year earlier.

Source · Based on the MD&A text of the filing

13-week gross profit margin, SG&A expense rate and operating income margin

The company said gross profit margin rose 80 basis points to 30.0% over the 13 weeks, selling, general and administrative expenses as a percentage of total revenue rose 200 basis points to 27.3%, and operating income margin was 2.8%. It cited unfavorable development of general liability claims as a factor in the higher SG&A expense rate.

Source · Based on the MD&A text of the filing

99 Cents Only lease designation rights and multi-price expansion

The company said it acquired designation rights for up to 170 leases of 99 Cents Only Stores in fiscal 2024 Q2, secured leases for 164 of these stores, and, as of August 3, 2024, had expanded its multi-price assortment to approximately 1,600 stores.

Source · Based on the MD&A text of the filing

26-week cash flow, share repurchases and borrowings

The company said operating cash flow increased $78.8 million over the 26 weeks, and it repurchased 3,283,837 shares of common stock for $403.6 million. As of August 3, 2024, the principal amount of commercial paper outstanding was $250.0 million, and long-term debt was $3.45 billion.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.